• Publications
  • Influence
Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy.
OBJECTIVES The aim of this study was to identify clinical features associated with peripartum cardiomyopathy (PPCM) and possible racial differences and to quantify in-hospital outcomes in deliveringExpand
  • 73
  • 5
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response
Patients with heart failure and preserved ejection fraction (HFpEF) have a poor prognosis, and no therapies have been proven to improve outcomes. It has been proposed that heart failure, includingExpand
  • 96
  • 3
Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?
OBJECTIVES The purpose of this study was to examine treatment practices for cancer therapy-associated decreased left ventricular ejection fraction (LVEF) detected on echocardiography and whetherExpand
  • 117
  • 2
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation
There is little evidence of beta‐blocker treatment benefit in patients with heart failure and reduced left ventricular ejection fraction (HFREF) and atrial fibrillation (AF). We investigated theExpand
  • 33
  • 2
Characteristics and In-Hospital Outcomes of Peripartum Cardiomyopathy Diagnosed During Delivery in the United States From the Nationwide Inpatient Sample (NIS) Database.
BACKGROUND Peripartum cardiomyopathy (PPCM) is associated with advanced maternal age, African-American race, hypertensive disorders of pregnancy, and multiple-gestation pregnancies. Less is knownExpand
  • 19
  • 2
Visual analysis of biological data-knowledge networks
BackgroundThe interpretation of the results from genome-scale experiments is a challenging and important problem in contemporary biomedical research. Biological networks that integrate experimentalExpand
  • 27
  • 2
The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association
The learning healthcare system uses health information technology and the health data infrastructure to apply scientific evidence at the point of clinical care while simultaneously collectingExpand
  • 40
  • 1
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use
Background  Sitagliptin is a new oral glucose‐lowering medication that acts via the incretin hormone system. The most common side‐effects are headache and pharyngitis, and few serious adverse eventsExpand
  • 44
  • 1
Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000-2006).
Renal insufficiency and anemia are increasingly recognized as predictors of adverse events in heart failure. The impact of blood transfusion on mortality in patients with heart failure has not beenExpand
  • 21
  • 1
Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
AIM To assess the relative frequency of reporting of adverse events involving ventricular arrhythmia, cardiac arrest, corrected QT interval (QTc) prolongation or torsade de pointes to the US Food andExpand
  • 23
  • 1